You are here: Industry Insights > contraceptive

News List

Pfizer, Myovant begin dosing in relugolix contraceptive study pharmatimes
April 15, 2021
Pfizer and Myovant have announced that dosing has begun in a Phase III study evaluating the contraceptive efficacy of their relugolix combination tablet.
Oral contraceptive pills protect against ovarian and endometrial cancer, study finds europeanpharmaceuticalreview
December 22, 2020
A study has shown that the use of oral contraceptives gave women a much lower risk of developing both ovarian and endometrial cancer.
Lubrizol Supports Women’s Health Worldwide contractpharma
September 17, 2020
Awarded grant for generic contraceptive injection research to advance women’s health around the globe.
Mayne Pharma Submits NDA to FDA for E4/DRSP contractpharma
April 17, 2020
Development and manufacturing partner Mithra can synthesise E4 at scale through a complex plant-based production process.
Bayer to commercialise Daré’s monthly contraceptive Ovaprene in US pharmaceutical-business-review
January 15, 2020
Bayer has entered into a licence agreement with Daré Bioscience to commercialise investigational contraceptive product called Ovaprene in the US.
Adolescent Oral Contraceptive Use Tied to Later Depression Risk drugs
September 04, 2019
There is a long-term association between adolescent oral contraceptive (OC) use and depression risk in adulthood, according to a study published online in the Journal of Child Psychology and Psychiatry.
HIV Risk Does Not Differ With Three Contraceptive Methods drugs
June 14, 2019
HIV Risk Does Not Differ With Three Contraceptive Methods.
Global contraceptive pill market to grow 6.6 percent europeanpharmaceuticalreview
June 10, 2019
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
Female Contraceptive Market set to be worth $8.7bn by 2027 biospectrumasia
February 12, 2019
China, on the other hand, will become the fourth largest contraceptive market by 2027
FDA Accepts Filing of New Estrogen-free Oral Contraceptive americanpharmaceuticalreview
November 30, 2018
Exeltis has received acceptance from the US Food and Drug Administration (FDA) of the filing of Slinda (4mg Drospirenone-only pill), the novel oral contraceptive developed by the company......

Previous page 1 2 Next page